Jubilant Ingrevia Limited — Important, 25-01-2025: Commencement of commercial production/operations

Jubilant Ingrevia Limited has commissioned a new cGMP compliant facility in Bharuch, Gujarat, dedicated to manufacturing Niacinamide and other dietary-active ingredients. This facility, which extends the company’s USFDA-approved operations, has a capacity of 5,000 Metric Tonnes and aims to meet the growing demand from global leaders in food, nutrition, and cosmetics.

The strategic addition positions Jubilant as one of the largest producers of Vitamin B3, potentially allowing it to dominate the high-value market segment while also venturing into the infant nutrition sector. The new facility, equipped for high bio-content productions, aligns with the company's green supply chain initiatives. CEO Deepak Jain emphasized the facility's role in enhancing their market presence and creating a strategic advantage against industry volatility. The move is expected to attract some of the most recognizable global brands, reflecting a positive outlook for future revenue streams and market share expansion. Investors should watch this development closely for its potential growth implications.